These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24201230)

  • 1. Heart rate variability during antidepressant treatment with venlafaxine and mirtazapine.
    Terhardt J; Lederbogen F; Feuerhack A; Hamann-Weber B; Gilles M; Schilling C; Lecei O; Deuschle M
    Clin Neuropharmacol; 2013; 36(6):198-202. PubMed ID: 24201230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural correlates of treatment outcome in major depression.
    Lisiecka D; Meisenzahl E; Scheuerecker J; Schoepf V; Whitty P; Chaney A; Moeller HJ; Wiesmann M; Frodl T
    Int J Neuropsychopharmacol; 2011 May; 14(4):521-34. PubMed ID: 21205435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
    Deuschle M; Gilles M; Scharnholz B; Lederbogen F; Lang UE; Hellweg R
    Pharmacopsychiatry; 2013 Mar; 46(2):54-8. PubMed ID: 22961097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.
    Scharnholz B; Weber-Hamann B; Lederbogen F; Schilling C; Gilles M; Onken V; Frankhauser P; Kopf D; Deuschle M
    Psychiatry Res; 2010 May; 177(1-2):109-13. PubMed ID: 20381159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
    Warden D; Trivedi MH; Carmody T; Toups M; Zisook S; Lesser I; Myers A; Kurian KR; Morris D; Rush AJ
    J Psychiatr Pract; 2014 Mar; 20(2):118-32. PubMed ID: 24638046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reboxetine adjunct for partial or nonresponders to antidepressant treatment.
    Rubio G; San L; López-Muñoz F; Alamo C
    J Affect Disord; 2004 Jul; 81(1):67-72. PubMed ID: 15183602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
    Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
    J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
    Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
    Kircanski K; Williams LM; Gotlib IH
    Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Antidepressants and Quetiapine on Heart Rate Variability.
    Huang WL; Liao SC; Kuo TB; Chang LR; Chen TT; Chen IM; Yang CC
    Pharmacopsychiatry; 2016 Sep; 49(5):191-198. PubMed ID: 27023265
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of cardiorespiratory coordination in young women with recurrent major depressive disorder treated with escitalopram or venlafaxine.
    Chang JS; Ha K; Yoon IY; Yoo CS; Yi SH; Her JY; Ha TH; Park T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):136-42. PubMed ID: 22699029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased platelet count after treatment with venlafaxine or mirtazapine in depressed patients.
    Gronau W; Paslakis G; Lederbogen F; Weber-Hamann B; Gilles M; Schilling C; Deuschle M
    Pharmacopsychiatry; 2015 Jan; 48(1):37-9. PubMed ID: 25402815
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
    Baune BT; Caliskan S; Todder D
    Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
    Carpenter LL; Yasmin S; Price LH
    Biol Psychiatry; 2002 Jan; 51(2):183-8. PubMed ID: 11822997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA).
    Yeh TC; Kao LC; Tzeng NS; Kuo TB; Huang SY; Chang CC; Chang HA
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():60-7. PubMed ID: 26216863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.